RFC
IMGN

Russell Frank Company’s Immunogen Inc IMGN Stock Holding History

Russell Frank Company’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-43,772
Closed -$629K – 3070
2015
Q2 		$629K Sell
43,772
-151,183
-78% -$1.66M ﹤0.01% 2513
2015
Q1 		$1.75M Buy
+194,955
New +$1.41M ﹤0.01% 1852
2013
Q4 		– Sell
-18,092
Closed -$308K – 3112
2013
Q3 		$308K Buy
18,092
+5,527
+44% +$97.2K ﹤0.01% 2645
2013
Q2 		$208K Buy
+12,565
New +$204K ﹤0.01% 2574

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Frank Company's IMGN Position: Q3 2015 in Review

Russell Frank Company sold out of Immunogen Inc (IMGN) in Q3 2015, closing a stake of 43,772 shares — an estimated $629K sold.

Russell Frank Company first reported a position in IMGN in Q2 2013 and held it in 4 quarters. The position peaked at $1.75M in Q1 2015. 151 funds tracked by Wall St. Rank hold IMGN as of Q3 2015.

  • Russell Frank Company reported no remaining Immunogen Inc position as of Q3 2015 after selling out during the quarter.
  • Russell Frank Company sold 43,772 Immunogen Inc shares in Q3 2015, an estimated $629K.
  • Russell Frank Company first reported a position in Immunogen Inc in Q2 2013 and held it in 4 quarters.
  • Russell Frank Company's Immunogen Inc position peaked at $1.75M in Q1 2015.
  • 151 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2015.

Based on Russell Frank Company's 13F filing for Q3 2015, filed 23 Oct 2015.